Home/Filings/4/0001209191-21-070453
4//SEC Filing

Lager Joanne Jenkins 4

Accession 0001209191-21-070453

CIK 0001808865other

Filed

Dec 16, 7:00 PM ET

Accepted

Dec 17, 7:59 PM ET

Size

8.8 KB

Accession

0001209191-21-070453

Insider Transaction Report

Form 4
Period: 2021-12-17
Lager Joanne Jenkins
Chief Medical Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2021-12-17$4.30/sh+7,000$30,1007,000 total
  • Sale

    Common Stock

    2021-12-17$41.00/sh7,000$287,0000 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2021-12-177,000196,438 total
    Exercise: $4.30Exp: 2025-06-11Common Stock (7,000 underlying)
Footnotes (2)
  • [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 23, 2021.
  • [F2]One-fourth of the shares subject to the stock option vested on April 1, 2020. Thereafter, 1/48 of the shares subject to the stock option vest on a monthly basis, subject to the reporting person's continuous service relationship with the Issuer through each applicable vesting date.

Issuer

iTeos Therapeutics, Inc.

CIK 0001808865

Entity typeother

Related Parties

1
  • filerCIK 0001816215

Filing Metadata

Form type
4
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 7:59 PM ET
Size
8.8 KB